A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Clinical Research Informatics Bookmark and Share

Clinical Research Informatics

Mission
The mission of Clinical Research Informatics (CRI)is to apply the science of information management to enable the effective and efficient execution of clinical research, including clinical trials, observational studies, and outcomes research.
 
Our key strategic goals to build a world-class clinical research informatics infrastructure by implementing best-in-class commercial solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal, CRI led the selection and implementation of the best-in-class electronic data capture (EDC) solution for clinical trials with the Medidata Rave EDC.CRI has also deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.
 
Services
  • Clinical Trials Management Systems (CTMS)
  • Electronic Data Capture (EDC)
  • Clinical Research Decision Support
 

Services

Clinical Trials Management Systems (CTMS)
Provide informatics solutions to manage the planning, execution, and reporting of clinical trials, such as protocol authoring, adverse event reporting, and subject enrollment
 
  • CTMS Evaluation Project
  • MIDAS
  • Clinical Trials On-Line (CTOL)

Electronic Data Capture
Provide electronic data capture (EDC) systems with electronic case report forms (eCRFs) or computer-scannable CRFs to capture study data, such as adverse events and tumor response
 
  • Medidata Rave EDC
  • TeleForms
     
Clinical Research Decision Support
Transforms data into decisions using business intelligence tools to report and analyze study-related data

  • Clinical Research Portal
  • TeleForms Work Bench
  • Clinical Trials On-Line (CTOL)
  • Medidata Rave EDC (Business Objects)
  • Automated Lab-Based Adverse Event Grader
  • Engraftment for Outcomes Research Decision Support
 

Clinical Research Informatics

Clinical Research Informatics

Mission
The mission of Clinical Research Informatics (CRI)is to apply the science of information management to enable the effective and efficient execution of clinical research, including clinical trials, observational studies, and outcomes research.
 
Our key strategic goals to build a world-class clinical research informatics infrastructure by implementing best-in-class commercial solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal, CRI led the selection and implementation of the best-in-class electronic data capture (EDC) solution for clinical trials with the Medidata Rave EDC.CRI has also deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.
 
Services
  • Clinical Trials Management Systems (CTMS)
  • Electronic Data Capture (EDC)
  • Clinical Research Decision Support
 

Services

Services

Clinical Trials Management Systems (CTMS)
Provide informatics solutions to manage the planning, execution, and reporting of clinical trials, such as protocol authoring, adverse event reporting, and subject enrollment
 
  • CTMS Evaluation Project
  • MIDAS
  • Clinical Trials On-Line (CTOL)

Electronic Data Capture
Provide electronic data capture (EDC) systems with electronic case report forms (eCRFs) or computer-scannable CRFs to capture study data, such as adverse events and tumor response
 
  • Medidata Rave EDC
  • TeleForms
     
Clinical Research Decision Support
Transforms data into decisions using business intelligence tools to report and analyze study-related data

  • Clinical Research Portal
  • TeleForms Work Bench
  • Clinical Trials On-Line (CTOL)
  • Medidata Rave EDC (Business Objects)
  • Automated Lab-Based Adverse Event Grader
  • Engraftment for Outcomes Research Decision Support
 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...
  • Providing lung cancer treatments to patients when their cancer is at its earliest and most treatable stages will now be a more attainable goal: Medicare has agreed to cover lung cancer screening for those beneficiaries who meet the requirements. The only proven way to detect lung cancer early enough to save liv...
  • At City of Hope, innovative scientific research, important clinical studies and vital construction projects are all powered by philanthropy. Generous supporters fuel a powerful and diverse range of progress in science and medicine, enabling researchers and clinicians to improve cancer treatments and create cure...
  • Trevor Hoffman was only 21 when he was diagnosed with a rare form of cancer, but not even cancer could keep him off his motorcycles. (He has one for racing, and a couple just for fun.) Now a cancer survivor, Hoffman, who lives in La Verne, California, wrapped up his treatment Jan. 19 – just one day […]
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...